U.S. reputation better after AIDS, malaria programs
Stanford researchers find favorability ratings of the United States increased in proportion to health aid, particularly after the implementation of AIDS relief and anti-malaria programs.
Democracy does wonders for health
The role of democracy in public health leads to dramatic decreases in deaths from noncommunicable diseases, HIV, cardiovascular disease and transportation injuries, according to a new study by researchers at Stanford and several other institutions.
Stanford Medicine focuses on global health
Stanford researchers, physicians and medical educators have built partnerships around the globe to try to solve some of the most vexing health problems.
Farming linked to gut microbiome changes
Researchers at Stanford and several other institutions have linked the gut ecosystems of four Himalayan groups to the extent of each group’s departure from a hunter-gatherer lifestyle.
First ENT clinic for children opens in Zimbabwe
Stanford’s Peter Koltai is participating in an effort to advance much-needed ENT care for children in Zimbabwe.
Decision scientist seeks hepatitis B solutions
Mehlika Toy merged her interests in infectious diseases and mathematics to forge a career in decision science. She builds models to estimate the impact of clinical interventions to inform health policy.
Toll of armed conflict in Africa
A Stanford-led analysis of the indirect impact of armed conflict in Africa shows that as many as 3.5 million infants born within 30 miles of combat were killed over two decades.
Toward a malaria vaccine for pregnant women
Prasanna Jagannathan said the $100,000 prize will allow his lab team to ramp up their research in Uganda.
IUD device aids contraception in India
Stanford researchers and their colleagues have tested a new contraceptive device that they say could provide broader access to long-acting contraception in developing countries.
Biomarker for flu susceptibility discovered
Scientists at Stanford are believed to be the first to have discovered a biomarker that can predict who will be most susceptible to influenza.
Could Nipah virus become global pandemic?
Stephen Luby discusses risk factors and potential interventions for Nipah virus, a disease with no vaccine and a mortality rate of up to 70 percent.
- Big Data
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- Developmental Biology
- Global Health
- Health Policy
- Infectious Disease
- Mental Health
- Patient Care
- Precision Health
- Preventive Medicine
- Stem Cells
- Women's Health